Search research articles
Contact Us
Filters
Showing results (21-30 of 747) with videos related to
Page
of 75
Sort By:
Annals of Internal Medicine
|
January 16, 2008
Association between body mass index and diabetes and hepatocellular carcinoma
Rohit Loomba, Marc Ghany
Current Opinion in Gastroenterology
|
April 11, 2014
State of the art: treatment of nonalcoholic steatohepatitis
Michelle Pearlman, Rohit Loomba
Journal of Clinical and Experimental Hepatology
|
June 17, 2024
Emerging Combination of Saroglitazar and Vitamin E for the Treatment of NAFLD and NASH
Federica Tavaglione, Rohit Loomba
Current Opinion in Gastroenterology
|
May 5, 2023
Advances in the genetics of nonalcoholic fatty liver disease
Veeral Ajmera, Rohit Loomba
Alimentary Pharmacology & Therapeutics
|
December 30, 2024
Editorial: Evaluating the Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinaemia-Authors' Reply
Maral Amangurbanova, Rohit Loomba
Hepatology (Baltimore, Md.)
|
March 11, 2024
Reply: Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC
Suzanne Sharpton, Rohit Loomba
Journal of Hepatology
|
October 9, 2025
Reply to: "Beyond a single snapshot: Considerations for PEth-guided subclassification of steatotic liver disease"
Federica Tavaglione, Rohit Loomba
Hepatology (Baltimore, Md.)
|
June 12, 2016
Reply
Jeffrey Cui, Rohit Loomba
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 29, 2018
Refining Sample-Size Estimations Based Upon Placebo Response in Trials of Agents for Nonalcoholic Fatty Liver Disease
Veeral Ajmera, Rohit Loomba
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 1, 2025
Reply
Mohammad Zamani, Rohit Loomba
Page
of 75
Search research articles
Search
Showing results (21-30 of 747) with videos related to
Sort By:
Page
of 75
Annals of Internal Medicine
|
January 16, 2008
Association between body mass index and diabetes and hepatocellular carcinoma
Rohit Loomba, Marc Ghany
Current Opinion in Gastroenterology
|
April 11, 2014
State of the art: treatment of nonalcoholic steatohepatitis
Michelle Pearlman, Rohit Loomba
Journal of Clinical and Experimental Hepatology
|
June 17, 2024
Emerging Combination of Saroglitazar and Vitamin E for the Treatment of NAFLD and NASH
Federica Tavaglione, Rohit Loomba
Current Opinion in Gastroenterology
|
May 5, 2023
Advances in the genetics of nonalcoholic fatty liver disease
Veeral Ajmera, Rohit Loomba
Alimentary Pharmacology & Therapeutics
|
December 30, 2024
Editorial: Evaluating the Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinaemia-Authors' Reply
Maral Amangurbanova, Rohit Loomba
Hepatology (Baltimore, Md.)
|
March 11, 2024
Reply: Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC
Suzanne Sharpton, Rohit Loomba
Journal of Hepatology
|
October 9, 2025
Reply to: "Beyond a single snapshot: Considerations for PEth-guided subclassification of steatotic liver disease"
Federica Tavaglione, Rohit Loomba
Hepatology (Baltimore, Md.)
|
June 12, 2016
Reply
Jeffrey Cui, Rohit Loomba
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 29, 2018
Refining Sample-Size Estimations Based Upon Placebo Response in Trials of Agents for Nonalcoholic Fatty Liver Disease
Veeral Ajmera, Rohit Loomba
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 1, 2025
Reply
Mohammad Zamani, Rohit Loomba
Page
of 75